My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 183

    1.

    Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed.

    Sawada-Hirai R, Jiang I, Wang F, Sun SM, Nedellec R, Ruther P, Alvarez A, Millis D, Morrow PR, Kang AS.

    J Immune Based Ther Vaccines. 2004 May 12;2(1):5.PMID: 15140257 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.

    Peterson JW, Comer JE, Noffsinger DM, Wenglikowski A, Walberg KG, Chatuev BM, Chopra AK, Stanberry LR, Kang AS, Scholz WW, Sircar J.

    Infect Immun. 2006 Feb;74(2):1016-24.PMID: 16428748 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.

    Staats HF, Alam SM, Scearce RM, Kirwan SM, Zhang JX, Gwinn WM, Haynes BF.

    Infect Immun. 2007 Nov;75(11):5443-52. Epub 2007 Aug 20.PMID: 17709410 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.

    Vitale L, Blanset D, Lowy I, O'Neill T, Goldstein J, Little SF, Andrews GP, Dorough G, Taylor RK, Keler T.

    Infect Immun. 2006 Oct;74(10):5840-7.PMID: 16988263 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.

    Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW.

    Infect Immun. 2007 Nov;75(11):5425-33. Epub 2007 Jul 23.PMID: 17646360 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.

    Hashimoto M, Boyer JL, Hackett NR, Wilson JM, Crystal RG.

    Infect Immun. 2005 Oct;73(10):6885-91.PMID: 16177368 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.

    Taft SC, Weiss AA.

    Clin Vaccine Immunol. 2008 Jan;15(1):71-5. Epub 2007 Nov 21.PMID: 18032590 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.

    Peterson JW, Comer JE, Baze WB, Noffsinger DM, Wenglikowski A, Walberg KG, Hardcastle J, Pawlik J, Bush K, Taormina J, Moen S, Thomas J, Chatuev BM, Sower L, Chopra AK, Stanberry LR, Sawada R, Scholz WW, Sircar J.

    Infect Immun. 2007 Jul;75(7):3414-24. Epub 2007 Apr 23.PMID: 17452469 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Development of a competitive enzyme linked immunosorbent assay to identify epitope specific antibodies in recipients of the U.S. licensed anthrax vaccine.

    Gubbins MJ, Schmidt L, Tsang RS, Berry JD, Kabani A, Stewart DI.

    J Immunoassay Immunochem. 2007;28(3):213-25.PMID: 17613668 [PubMed - indexed for MEDLINE]Related articles

    10.

    Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly.

    Wang F, Ruther P, Jiang I, Sawada-Hirai R, Sun SM, Nedellec R, Morrow PR, Kang AS.

    Hum Antibodies. 2004;13(4):105-10.PMID: 15671576 [PubMed - indexed for MEDLINE]Related articles

    11.

    Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed.

    Reason D, Liberato J, Sun J, Keitel W, Zhou J.

    Infect Immun. 2009 May;77(5):2030-5. Epub 2009 Feb 17.PMID: 19223482 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.

    Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P.

    Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13601-6. Epub 2004 Sep 1.PMID: 15342913 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Selection and characterization of human antibodies neutralizing Bacillus anthracis toxin.

    Zhou B, Carney C, Janda KD.

    Bioorg Med Chem. 2008 Feb 15;16(4):1903-13. Epub 2007 Nov 5.PMID: 18023190 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.

    Kelly-Cirino CD, Mantis NJ.

    Infect Immun. 2009 Nov;77(11):4859-67. Epub 2009 Aug 24.PMID: 19703971 [PubMed - indexed for MEDLINE]Related articles

    15.

    An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals.

    Hewetson JF, Little SF, Ivins BE, Johnson WM, Pittman PR, Brown JE, Norris SL, Nielsen CJ.

    Vaccine. 2008 Aug 5;26(33):4262-6. Epub 2008 Jun 12.PMID: 18586363 [PubMed - indexed for MEDLINE]Related articles

    16.

    Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.

    Park YS, Lee JH, Hung CF, Wu TC, Kim TW.

    Infect Immun. 2008 May;76(5):1952-9. Epub 2008 Feb 19.PMID: 18285494 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant.

    Kelly CD, O'Loughlin C, Gelder FB, Peterson JW, Sower LE, Cirino NM.

    J Immune Based Ther Vaccines. 2007 Oct 22;5:11.PMID: 17953756 [PubMed - in process]Related articlesFree article

    18.

    Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody.

    Chen Z, Moayeri M, Crown D, Emerson S, Gorshkova I, Schuck P, Leppla SH, Purcell RH.

    Infect Immun. 2009 Sep;77(9):3902-8. Epub 2009 Jun 15.PMID: 19528217 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.

    Nguyen ML, Crowe SR, Kurella S, Teryzan S, Cao B, Ballard JD, James JA, Farris AD.

    Infect Immun. 2009 Jan;77(1):162-9. Epub 2008 Nov 3.PMID: 18981257 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.

    Williamson ED, Hodgson I, Walker NJ, Topping AW, Duchars MG, Mott JM, Estep J, Lebutt C, Flick-Smith HC, Jones HE, Li H, Quinn CP.

    Infect Immun. 2005 Sep;73(9):5978-87.PMID: 16113318 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk